指南与共识骨质疏松与代谢性骨病

真实世界证据:骨质疏松研究的新机遇——欧洲骨质疏松、骨关节炎和肌肉骨骼疾病临床与经济学会(ESCEO)工作组的建议

Real-world evidence: new opportunities for osteoporosis research. Recommendations from a Working Group from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO).
指南 / 共识 · Osteoporos Int · 2023-06-23

ESCEO工作组于2022年12月召开会议,讨论真实世界证据(RWE)在骨质疏松研究中的适用性与最佳实践方法。本叙述性综述汇总了工作组关于RWE研究实施与报告的建议,强调研究应遵循最高标准,密切关注数据局限与偏倚,并在研究设计、数据获取与整理、分析及报告各阶段保持透明,以提高RWE研究结果的可信度。

要点

  • RWE可用于描述疾病自然史、评估真实世界药物有效性、了解不良事件及用于卫生经济学分析。
  • 使用真实世界数据开展研究须遵循最高标准,并密切关注数据的局限性与偏倚。
  • 研究设计、数据获取与整理、分析及报告各阶段均应保持透明,以提高RWE研究结果的可信度。

核心结论

  • 使用真实世界数据的研究必须以最高标准开展,密切关注这些数据的局限性和偏倚。
  • 在研究设计、数据获取与整理、分析及报告的所有阶段保持透明,以提高RWE研究结果的可信度。

研究设计与样本

  • ESCEO工作组于2022年12月召开会议,讨论RWE在骨质疏松研究中的适用性及最佳实践方法。
  • 本文为叙述性综述,汇总了工作组关于RWE研究实施与报告的建议。

主要发现

  • 真实世界数据在每次医疗接触和活动中常规产生,人们日益认识到这些数据可被分析以生成科学证据。
  • RWE越来越多地用于描述疾病自然史、评估真实世界药物有效性、了解不良事件及用于卫生经济学分析。

局限性

  • 原文提及真实世界数据存在局限性和偏倚,研究需密切关注这些局限性和偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: This narrative review summarises the recommendations of a Working Group of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) for the conduct and reporting of real-world evidence studies with a focus on osteoporosis research. PURPOSE: Vast amounts of data are routinely generated at every healthcare contact and activity, and there is increasing recognition that these real-world data can be analysed to generate scientific evidence. Real-world evidence (RWE) is increasingly used to delineate the natural history of disease, assess real-life drug effectiveness, understand adverse events and in health economic analysis. The aim of this work was to understand the benefits and limitations of this type of data and outline approaches to ensure that transparent and high-quality evidence is generated. METHODS: A ESCEO Working Group was convened in December 2022 to discuss the applicability of RWE to osteoporosis research and approaches to best practice. RESULTS: This narrative review summarises the agreed recommendations for the conduct and reporting of RWE studies with a focus on osteoporosis research. CONCLUSIONS: It is imperative that research using real-world data is conducted to the highest standards with close attention to limitations and biases of these data, and with transparency at all stages of study design, data acquisition and curation, analysis and reporting to increase the trustworthiness of RWE study findings.

来源:Osteoporos Int,查看原文。版权归原作者所有。

引用

  1. Moon RJ, Reginster JY, Al-Daghri NM, et al. Real-world evidence: new opportunities for osteoporosis research. Recommendations from a Working Group from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO). Osteoporos Int. 2023. PMID: 37351614. doi:10.1007/s00198-023-06827-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。